基于外泌体miRNA靶向诊疗结直肠癌的研究进展

doi:10.20047/j.issn1673-7210.2023.05.10

Abstract
Figure/Table
References (36)
Related Citation (15)

Download: PDF (485 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract MiRNA derived from circulating exosome regulate the development of colorectal cancer from both cell metabolism and tumor microenvironment aspects. In addition, exosomal miRNA has the potential to reflect the staging, therapeutic efficacy, chemotherapy resistance and recurrence risks of colorectal cancer. Based on its biological characteristics, we systematically reviewed that exosomal miRNA work as biomarkers for the diagnosis and prognosis of colorectal cancer, which were reported in related research, and we also summarized the mechanisms related to targeted treatment of colorectal cancer based on exsomal miRNA, in order to provide a theoretical basis for exosomal miRNA functioning as core biological markers and innovative therapeutic targets for colorectal cancer.

Key words： Exosome MiRNA Colorectal cancer Biomarker Targeted therapy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Yuting WANG Anqi LI Zhili LYU Zhengrong HUANG Chuyue FAN Zhimin

Cite this article:

WANG Yuting WANG Anqi LI Zhili LYU Zhengrong HUANG Chuyue FAN Zhimin. Research progress of targeted diagnosis and treatment of colorectal cancer based on exosomal miRNA[J]. 中国医药导报, 2023, 20(5): 47-50.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.05.10 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I5/47

[1] Siegel RL，Miller KD，Fuchs HE，et al. Cancer statistics，2022 [J]. CA Cancer J Clin，2022，72（1）：7-33.
[2] Li W，Zhao LZ，Ma DW，et al. Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test [J]. Medicine（Baltimore），2018，97（18）：e0529.
[3] Alves Dos Santos K，Clemente Dos Santos IC，Santos Silva C，et al. Circulating exosomal miRNAs as biomarkers for the diagnosis and prognosis of colorectal cancer [J]. Int J Mol Sci，2020，22（1）：346.
[4] Scavo MP，Rizzi F，Depalo N，et al. A possible role of FZD10 delivering exosomes derived from colon cancers cell lines in inducing activation of epithelial-mesenchymal transition in normal colon epithelial cell line [J]. Int J Mol Sci，2020，21（18）：6705.
[5] Li M，Qian X，Zhu M，et al. miR1273g3p promotes proliferation，migration and invasion of LoVo cells via cannabinoid receptor 1 through activation of ERBB4/PIK3R3/mTOR/ S6K2 signaling pathway [J]. Mol Med Rep，2018，17（3）：4619- 4626.
[6] Liu J，Ren L，Li S，et al. The biology，function，and applications of exosomes in cancer [J]. Acta Pharm Sin B，2021，11（9）：2783-2797.
[7] Zhou J，Li XL，Chen ZR，et al. Tumor-derived exosomes in colorectal cancer progression and their clinical applications [J]. Oncotarget，2017，8（59）：100781-100790.
[8] Li K，Chen Y，Li A，et al. Exosomes play roles in sequential processes of tumor metastasis [J]. Int J Cancer，2019，144（7）：1486-1495.
[9] Maas S，Breakefield XO，Weaver AM. Extracellular vesicles：unique intercellular delivery vehicles [J]. Trends Cell Biol，2017，27（3）：172-188.
[10] Chen L，Heikkinen L，Wang C，et al. Trends in the development of miRNA bioinformatics tools [J]. Brief Bioinform，2019，20（5）：1836-1852.
[11] Jin H，Qiao F，Wang Y，et al. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway [J]. Oncol Rep，2015，34（5）：2782-2789.
[12] Chen X，Su X，Lin M，et al. Expression of miR-192-5p in colon cancer serum and its relationship with clinicopathologic features [J]. Am J Transl Res，2021，13（8）：9371-9376.
[13] 常文婧，商安全，杨滇宇，等.血清外泌体miR-218-5p在结直肠癌中的表达水平及临床应用价值[J].中华检验医学杂志，2021，44（8）：709-714.
[14] Barisciano G，Colangelo T，Rosato V，et al. miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer [J]. Br J Cancer，2020，122（9）：1354-1366.
[15] Chen W，Tong K，Yu J. MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2 [J]. Mol Med Rep，2017，16（4）：5241-5248.
[16] Bastaminejad S，Taherikalani M，Ghanbari R，et al. Investigation of MicroRNA-21 expression levels in serum and stool as a potential non-invasive biomarker for diagnosis of colorectal cancer [J]. Iran Biomed J，2017，21（2）：106-113.
[17] Al-Sheikh YA，Ghneim HK，Softa KI，et al. Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR [J]. Oncol Lett，2016，11（2）：1406-1412.
[18] Liang L，Gao C，Li Y，et al. miR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation，migration，invasion and pathological angiogenesis via PI3K-Akt pathway [J]. Cell Death Dis，2017，8（8）：e2968.
[19] Jung G，Hernández-Illán E，Moreira L，et al. Epigenetics of colorectal cancer：biomarker and therapeutic potential [J]. Nat Rev Gastroenterol Hepatol，2020，17（2）：111-130.
[20] Kosaka N，Yoshioka Y，Fujita Y，et al. Versatile roles of extracellular vesicles in cancer [J]. J Clin Invest，2016，126（4）：1163-1172.
[21] Toiyama Y，Takahashi M，Hur K，et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer [J]. J Natl Cancer Inst，2013，105（12）：849-859.
[22] Wu Y，Song Y，Xiong Y，et al. MicroRNA-21 （Mir-21） promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer [J]. Cell Physiol Biochem，2017，43（3）：945-958.
[23] Sun Z，Shi K，Yang S，et al. Effect of exosomal miRNA on cancer biology and clinical applications [J]. Mol Cancer，2018，17（1）：147.
[24] Toiyama Y，Hur K，Tanaka K，et al. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer [J]. Ann Surg，2014，259（4）：735-743.
[25] Cho WC，Kim M，Park JW，et al. Exosomal miR-193a and let-7g accelerate cancer progression on primary colorectal cancer and paired peritoneal metastatic cancer [J]. Transl Oncol，2021，14（2）：101000.
[26] Sun X，Lin F，Sun W，et al. Exosome-transmitted miRNA- 335-5p promotes colorectal cancer invasion and metastasis by facilitating EMT via targeting RASA1 [J]. Mol Ther Nucleic Acids，2021，24：164-174.
[27] Maleki M，Golchin A，Javadi S，et al. Role of exosomal miRNA in chemotherapy resistance of COLORECTAL cancer：a systematic review [J]. Chem Biol Drug Des，2021. Online ahead of print.
[28] Jin G，Liu Y，Zhang J，et al. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer [J]. Cancer Chemother Pharmacol，2019，84（2）：315-325.
[29] Liu T，Zhang X，Du L，et al. Exosome-transmitted miR-128- 3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer [J]. Mol Cancer，2019，18（1）：43.
[30] Chinnappan M，Srivastava A，Amreddy N，et al. Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs [J]. Cancer Lett，2020，486：18-28.
[31] Wu K，Xing F，Wu SY，et al. Extracellular vesicles as emerging targets in cancer：recent development from bench to bedside [J]. Biochim Biophys Acta Rev Cancer，2017， 1868（2）：538-563.
[32] Liang G，Zhu Y，Ali DJ，et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer [J]. J Nanobiotechnology，2020，18（1）：10.
[33] Han S，Li G，Jia M，et al. Delivery of anti-miRNA-221 for colorectal carcinoma therapy using modified cord blood mesenchymal stem cells-derived exosomes [J]. Front Mol Biosci，2021，8：743013.
[34] Ma J，Wang P，Huang L，et al. Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer [J]. BMC Med Genomics，2021，14（1）：60.
[35] Maminezhad H，Ghanadian S，Pakravan K，et al. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer [J]. Life Sci，2020， 258：118226.
[36] Pourdavoud P，Pakzad B，Mosallaei M，et al. MiR-196：emerging of a new potential therapeutic target and biomarker in colorectal cancer [J]. Mol Biol Rep，2020，47（12）：9913- 9920.